These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3329 related articles for article (PubMed ID: 12407406)

  • 1. Cancer immunoediting: from immunosurveillance to tumor escape.
    Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD
    Nat Immunol; 2002 Nov; 3(11):991-8. PubMed ID: 12407406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunobiology of cancer immunosurveillance and immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunoediting and immunosculpting pathways to cancer progression.
    Reiman JM; Kmieciak M; Manjili MH; Knutson KL
    Semin Cancer Biol; 2007 Aug; 17(4):275-87. PubMed ID: 17662614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
    Schreiber RD; Old LJ; Smyth MJ
    Science; 2011 Mar; 331(6024):1565-70. PubMed ID: 21436444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
    Vesely MD; Schreiber RD
    Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The three Es of cancer immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Annu Rev Immunol; 2004; 22():329-60. PubMed ID: 15032581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
    Matsushita H; Vesely MD; Koboldt DC; Rickert CG; Uppaluri R; Magrini VJ; Arthur CD; White JM; Chen YS; Shea LK; Hundal J; Wendl MC; Demeter R; Wylie T; Allison JP; Smyth MJ; Old LJ; Mardis ER; Schreiber RD
    Nature; 2012 Feb; 482(7385):400-4. PubMed ID: 22318521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma and cancer immunoediting.
    Dunn GP; Ikeda H; Bruce AT; Koebel C; Uppaluri R; Bui J; Chan R; Diamond M; White JM; Sheehan KC; Schreiber RD
    Immunol Res; 2005; 32(1-3):231-45. PubMed ID: 16106075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between immunological defence and the development of tumours].
    Leone G
    Arch Sci Med (Torino); 1973; 130(4):273-82. PubMed ID: 17343168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tumour-specific antigens underlies cancer immunoediting.
    DuPage M; Mazumdar C; Schmidt LM; Cheung AF; Jacks T
    Nature; 2012 Feb; 482(7385):405-9. PubMed ID: 22318517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens.
    Tveita AA; Schjesvold F; Haabeth OA; Fauskanger M; Bogen B
    Cancer Res; 2015 Aug; 75(16):3268-78. PubMed ID: 26038231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunosurveillance and immunoediting by natural killer cells.
    Gross E; Sunwoo JB; Bui JD
    Cancer J; 2013; 19(6):483-9. PubMed ID: 24270347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and prospects of immunotherapy as cancer treatment.
    Rescigno M; Avogadri F; Curigliano G
    Biochim Biophys Acta; 2007 Sep; 1776(1):108-23. PubMed ID: 17720322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic escape of immunosurveillance by malignant cell precursors.
    Galassi C; Galluzzi L
    EMBO J; 2023 May; 42(10):e114050. PubMed ID: 37051718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concept of immune surveillance against tumors. The first theories.
    Ribatti D
    Oncotarget; 2017 Jan; 8(4):7175-7180. PubMed ID: 27764780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural selection of tumor variants in the generation of "tumor escape" phenotypes.
    Khong HT; Restifo NP
    Nat Immunol; 2002 Nov; 3(11):999-1005. PubMed ID: 12407407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
    WilczyƄski JR; Nowak M
    Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges.
    Kunimasa K; Goto T
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 167.